rs786201010

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_004064.5(CDKN1B):​c.-454_-451delTTCC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000196 in 1,019,002 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000020 ( 0 hom. )

Consequence

CDKN1B
NM_004064.5 5_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 3.55

Publications

6 publications found
Variant links:
Genes affected
CDKN1B (HGNC:1785): (cyclin dependent kinase inhibitor 1B) This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4). [provided by RefSeq, Apr 2014]
GPR19 (HGNC:4473): (G protein-coupled receptor 19) Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in cilium. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1BNM_004064.5 linkc.-454_-451delTTCC 5_prime_UTR_variant Exon 1 of 3 ENST00000228872.9 NP_004055.1 P46527Q6I9V6
GPR19XM_011520623.4 linkc.-1881_-1878delAAGG upstream_gene_variant XP_011518925.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1BENST00000228872.9 linkc.-454_-451delTTCC 5_prime_UTR_variant Exon 1 of 3 1 NM_004064.5 ENSP00000228872.4 P46527

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
0.00000196
AC:
2
AN:
1019002
Hom.:
0
AF XY:
0.00000209
AC XY:
1
AN XY:
478606
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
21748
American (AMR)
AF:
0.00
AC:
0
AN:
7696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
12222
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19090
South Asian (SAS)
AF:
0.00
AC:
0
AN:
36564
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2468
European-Non Finnish (NFE)
AF:
0.00000229
AC:
2
AN:
874022
Other (OTH)
AF:
0.00
AC:
0
AN:
39086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Multiple endocrine neoplasia type 4 Pathogenic:1
Mar 01, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Hereditary cancer-predisposing syndrome Uncertain:1
May 22, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.-454_-451delTTCC variant is located in the 5' untranslated region (5'UTR) of the CDKN1B gene. This variant results from a deletion of four nucleotides 451 nucleotides upstream from the first translated codon. This variant has been observed in at least one individual with a personal and/or family history that is consistent with CDKN1B-related multiple endocrine neoplasia (Occhi G et al. PLoS Genet, 2013 Mar;9:e1003350). Functional studies have demonstrated an inhibitory effect of this variant on CDKN1B expression (Occhi G et al. PLoS Genet, 2013 Mar;9:e1003350).. Based on the available evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.5
Mutation Taster
=72/228
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs786201010; hg19: chr12-12870317; API